CG Health Ventures

CG Health Ventures is a venture capital firm established in 2015 and based in Barcelona, Spain. The firm focuses on investing in early-stage companies within the health IT, digital health, and genomics sectors. Targeting opportunities primarily in Europe and the United States, CG Health Ventures aims to support innovative healthcare solutions that can enhance patient outcomes and transform the industry.

Pablo Prieto

Managing Director

7 past transactions

Amelia Virtual Care

Series A in 2022
Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.

Skingdom

Seed Round in 2017
Skingdom is a new digital e-health startup, Coachmetics aims to become the international reference in wellness coaching.

Babyscripts

Series A in 2017
Babyscripts is a digital health platform focused on enhancing prenatal and postpartum care through a virtual approach. Designed to strengthen the relationship between patients and healthcare providers, it offers a mobile app that guides expectant mothers through their pregnancy journey with tasks related to nutrition, exercise, and other relevant behaviors. Upon enrollment by their OBGYN, patients receive a Mommy Kit, which includes internet-enabled devices such as a weight scale and blood pressure cuff. This setup allows mothers to monitor their health at home while staying connected with their healthcare providers. The app automatically captures health readings and compliance data, facilitating real-time feedback and intervention. Babyscripts collaborates with major health systems to improve care for high-risk pregnancies, continuously refining its offerings to reach more expecting mothers and address critical issues such as maternal mortality.

Virta Health

Series A in 2017
Virta Health operates an online specialty medical clinic focused on reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, the company combines nutritional biochemistry, clinical expertise, data science, and digital tools to develop its treatment protocols. Through its continuous remote care platform, Virta provides medical and behavioral support to patients, resulting in significant health improvements. In clinical trials, 60% of participants achieved diabetes reversal within one year, and 94% of insulin users were able to reduce or eliminate their insulin usage. The benefits of Virta's treatment extend to other aspects of metabolic and cardiovascular health, demonstrating sustained improvements in blood pressure, inflammation, liver function, and body mass index (BMI).

S-Biomedic

Seed Round in 2016
S-Biomedic is a Belgian biotech company specializing in live probiotic cosmetics designed to improve skin health. The company focuses on the skin microbiome, a complex ecosystem of beneficial and harmful bacteria that plays a crucial role in skin conditions such as acne, eczema, rosacea, and aging. S-Biomedic employs advanced modulation-based technology to selectively harness beneficial bacteria, creating products that promote the rebalancing of the skin microbiome. By utilizing the latest advancements in microbiology and dermatology, their offerings aim to restore healthy skin and address various dermatological concerns. Through this innovative approach, S-Biomedic provides therapeutic solutions in both the dermatology and cosmetic sectors, enhancing the overall health and beauty of the skin.

Genomcore

Seed Round in 2016
Genomcore, SL is a personal genomics company based in Esplugues De Llobregat, Spain, founded in 2015. The company specializes in personalized well-being, health promotion, and genetic prevention, offering services that include the collection and analysis of blood samples. Following the analysis, Genomcore provides advisory support through health coaches or genetic counselors and delivers health guides digitally and in personalized printed formats. In addition, Genomcore operates as a bioinformatics framework that emphasizes privacy and compliance, facilitating the implementation of precision healthcare in clinical settings. The company also supports the development of new protocols and services that bridge biomedical research and primary care.

Medtep

Seed Round in 2015
Medtep Inc. develops medical software solutions aimed at fostering connections between healthcare professionals and patients. The company's primary offerings, uClinics and uPatient, enable healthcare providers to prescribe and assess patients while allowing patients to gain a better understanding of their health and treatment plans. These solutions are accessible on various devices, including computers, tablets, and smartphones. By integrating data from multiple sources such as applications, devices, and sensors, Medtep enhances patient monitoring and promotes informed health decisions. Founded in 2011 and headquartered in Redwood City, California, Medtep serves a diverse clientele that includes medical societies, pharmaceutical companies, clinical laboratories, sports clubs, patient associations, foundations, insurance firms, universities, and research and development centers. Through its focus on personalized medicine and disease prevention, Medtep empowers patients to take an active role in managing their health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.